Endostatin in Treating Patients With Advanced Solid Tumors

NCT00004229 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: recombinant human endostatin

Sponsor

National Cancer Institute (NCI)